Health Capital Helsinki (HCH) invites innovative pharmaceutical companies to join as Founding Pharma Partners. This entry-level partnership offers a way to demonstrate commitment to advancing health innovations in the Helsinki
Join Health Capital Helsinki as a Founding Pharma Partner Read More »
How can your health tech startup stay secure in a world of increasing cybersecurity challenges?
Free training materials: Cybersecurity for health startups and growth companies Read More »
10 health and life sciences startups with high growth potential have been selected for Health Incubator Helsinki, Finland’s unique health incubator programme. The new batch of startups started in the
Meet the 10 new Health Incubator Helsinki startups Read More »
TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has been awarded a $2M grant from the U.S Department of Defense (DOD). Helsinki-based TILT Biotherapeutics is recognised as one of
Helsinki-based TILT Biotherapeutics raises $2M for ovarian cancer immunotherapy research Read More »
Health Incubator Helsinki, Finland’s first long-term incubator program for research-based health sector startups and teams, is accepting applications until 31 March 2024! Collaborating with talented people is fundamental to the
Health Incubator Helsinki is open for applications – apply by 31 March Read More »
Supportive startup infrastructure, excellent health data, and a wealth of research innovation make Helsinki a health & life sciences city to watch.
Helsinki – a health & life sciences city to watch Read More »
Presenting Health Incubator Helsinki batch 4 companies: AuxCuro addresses challenges such as nurse burnout, medical errors, and communication gaps in hospitals between personnel. The platform offers decision support, better communication
AuxCuro’s virtual health assistance to equip nurses with AI for comprehensive care Read More »
Photo: The European Society of Cardiology at Radical Health Festival Helsinki 2023. The European Society of Cardiology (ESC) and Radical Health Festival Helsinki continue their partnership for the upcoming event
ESC partners with Radical Health Festival Helsinki 2024 Read More »
The FinnGen research consortium has successfully collected and generated genomic data from 500,000 individuals in Finland. Now, the project will continue its search for genetic clues to disease progression and
World-leading FinnGen study enters next phase with €52M of new funding Read More »
The event continues its transformative mission Following the successful conclusion of the inaugural pan-European Radical Health Festival Helsinki, the event will make its second appearance on 22-23 May, 2024 at
Radical Health Festival Helsinki returns for second edition in 2024 Read More »
